| Dr Brad William Shufelt, MD | |
|
5875 E Riverside Blvd, Rockford, IL 61114-4937 | |
| (815) 398-9491 | |
| (815) 381-7498 |
| Full Name | Dr Brad William Shufelt |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 16 Years |
| Location | 5875 E Riverside Blvd, Rockford, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407013832 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 036127778 (Illinois) | Primary |
| 207L00000X | Anesthesiology | 81898-20 (Wisconsin) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthomidwest Pllc | 0749183713 | 386 |
News Archive
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.
Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases.
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.
Scientists from UCLA are now bringing their groundbreaking stem cell science directly to patients in two exciting new clinical trials scheduled to begin in early 2014, thanks to funding from California's stem cell agency.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended March 31, 2010.
› Verified 2 days ago
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.
Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases.
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.
Scientists from UCLA are now bringing their groundbreaking stem cell science directly to patients in two exciting new clinical trials scheduled to begin in early 2014, thanks to funding from California's stem cell agency.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended March 31, 2010.
› Verified 2 days ago
| Entity Name | Orthomidwest Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730136474 PECOS PAC ID: 0749183713 Enrollment ID: O20040128000533 |
News Archive
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.
Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases.
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.
Scientists from UCLA are now bringing their groundbreaking stem cell science directly to patients in two exciting new clinical trials scheduled to begin in early 2014, thanks to funding from California's stem cell agency.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended March 31, 2010.
› Verified 2 days ago
| Entity Name | Central Dupage Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033149844 PECOS PAC ID: 5890696231 Enrollment ID: O20040303000601 |
News Archive
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.
Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases.
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.
Scientists from UCLA are now bringing their groundbreaking stem cell science directly to patients in two exciting new clinical trials scheduled to begin in early 2014, thanks to funding from California's stem cell agency.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended March 31, 2010.
› Verified 2 days ago
| Entity Name | Huntley Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205282019 PECOS PAC ID: 0143515825 Enrollment ID: O20160819000149 |
News Archive
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.
Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases.
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.
Scientists from UCLA are now bringing their groundbreaking stem cell science directly to patients in two exciting new clinical trials scheduled to begin in early 2014, thanks to funding from California's stem cell agency.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended March 31, 2010.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brad William Shufelt, MD Po Box 735263, Chicago, IL 60673-5263 Ph: () - | Dr Brad William Shufelt, MD 5875 E Riverside Blvd, Rockford, IL 61114-4937 Ph: (815) 398-9491 |
News Archive
Kamada, a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced that data on its next-generation alpha-1 antitrypsin (Inhaled-AAT) in cystic fibrosis patients was presented today, at the Annual Congress of the European Respiratory Society (ERS) 2009, Vienna. As previously reported, the study showed that inhaled-AAT was safe and biologically effective.
Although influenza vaccines are currently the best forms of protection to safeguard people against getting the flu, they are not effective in all cases.
New UCLA-led research indicates that simple text messages emphasizing the easy availability of COVID-19 vaccines successfully boosted the number of people who got the shot.
Scientists from UCLA are now bringing their groundbreaking stem cell science directly to patients in two exciting new clinical trials scheduled to begin in early 2014, thanks to funding from California's stem cell agency.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended March 31, 2010.
› Verified 2 days ago
Mark J. Kellen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 Fax: 815-381-7498 | |
Alan G Mowbray, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2400 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-4000 | |
John N. Edwards, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6785 Weaver Rd, Suite D, Rockford, IL 61114 Phone: 815-633-8545 | |
Dr. Vishrut P. Naik, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 | |
Adam Soliman, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 Fax: 815-381-7498 | |
Dr. William Stephen Minore, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1235 N Mulford Rd Ste 222, Rockford, IL 61107 Phone: 815-397-8400 Fax: 815-229-0050 | |
Stephen J. Martin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 Fax: 815-381-7498 |